KR20080038335A - 올로파타딘을 포함하는 경피 흡수 안과 제제 - Google Patents

올로파타딘을 포함하는 경피 흡수 안과 제제 Download PDF

Info

Publication number
KR20080038335A
KR20080038335A KR1020087003138A KR20087003138A KR20080038335A KR 20080038335 A KR20080038335 A KR 20080038335A KR 1020087003138 A KR1020087003138 A KR 1020087003138A KR 20087003138 A KR20087003138 A KR 20087003138A KR 20080038335 A KR20080038335 A KR 20080038335A
Authority
KR
South Korea
Prior art keywords
olopatadine
formulation
subject
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087003138A
Other languages
English (en)
Korean (ko)
Inventor
아키하루 이소와키
토모코 나카지마
아키라 오토리
Original Assignee
센주 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 센주 세이야꾸 가부시키가이샤 filed Critical 센주 세이야꾸 가부시키가이샤
Publication of KR20080038335A publication Critical patent/KR20080038335A/ko
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020087003138A 2005-07-08 2006-07-07 올로파타딘을 포함하는 경피 흡수 안과 제제 Ceased KR20080038335A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69736805P 2005-07-08 2005-07-08
US60/697,368 2005-07-08

Publications (1)

Publication Number Publication Date
KR20080038335A true KR20080038335A (ko) 2008-05-06

Family

ID=37022903

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087003138A Ceased KR20080038335A (ko) 2005-07-08 2006-07-07 올로파타딘을 포함하는 경피 흡수 안과 제제

Country Status (7)

Country Link
US (1) US8101654B2 (enExample)
EP (1) EP1901708B1 (enExample)
JP (1) JP5315051B2 (enExample)
KR (1) KR20080038335A (enExample)
CN (1) CN101217937A (enExample)
ES (1) ES2437077T3 (enExample)
WO (1) WO2007007863A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1591110B1 (en) * 2003-01-22 2015-03-18 Senju Pharmaceutical Co., Ltd. Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
CN101217948A (zh) * 2005-07-08 2008-07-09 千寿制药株式会社 包含依匹那丁的透皮吸收眼科制剂
CN101528211B (zh) * 2006-08-28 2012-10-10 千寿制药株式会社 眼用经皮吸收型制剂
US20110104083A1 (en) * 2009-10-30 2011-05-05 Intratus, Inc. Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
EP3827823A1 (en) * 2012-12-19 2021-06-02 Novartis AG Lfa-1 inhibitor formulations
WO2016182032A1 (ja) * 2015-05-12 2016-11-17 参天製薬株式会社 アゾール系抗真菌薬の眼瞼皮膚への投与
CN106324111A (zh) * 2015-06-24 2017-01-11 江苏吉贝尔药业股份有限公司 一种盐酸奥洛他定滴眼液的检测方法
TWI825013B (zh) * 2017-04-19 2023-12-11 日商帝國製藥股份有限公司 含有盧帕他定(rupatadine)之貼附劑
CN107823124B (zh) * 2017-11-09 2018-11-27 广州博济医药生物技术股份有限公司 一种盐酸奥洛他定外用组合物及其乳膏剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US5744151A (en) * 1995-06-30 1998-04-28 Capelli; Christopher C. Silver-based pharmaceutical compositions
JPH09194396A (ja) * 1996-01-17 1997-07-29 Pola Chem Ind Inc 貼付剤用マトリックス
DK1187617T3 (da) * 1999-06-18 2004-04-13 Alcon Mfg Ltd Fremgangsmåde til at vælge koncentrationen af et amfipatisk antihistaminlægemiddel ved at bestemme lægemidlets overfladeaktivitetsmåltal
US7615237B1 (en) * 1999-07-15 2009-11-10 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable preparations
JP4653893B2 (ja) * 2000-01-27 2011-03-16 純一 須藤 二層型経皮吸収製剤
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
EP1591110B1 (en) * 2003-01-22 2015-03-18 Senju Pharmaceutical Co., Ltd. Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye

Also Published As

Publication number Publication date
JP5315051B2 (ja) 2013-10-16
US20090209632A1 (en) 2009-08-20
EP1901708A1 (en) 2008-03-26
CN101217937A (zh) 2008-07-09
JP2009500398A (ja) 2009-01-08
ES2437077T3 (es) 2014-01-08
WO2007007863A1 (en) 2007-01-18
US8101654B2 (en) 2012-01-24
EP1901708B1 (en) 2013-09-11

Similar Documents

Publication Publication Date Title
JP4629578B2 (ja) 眼疾患治療用経皮吸収型製剤
EP2493474B1 (en) Methods and compositions for sustained delivery of drugs
US20090318422A1 (en) Ophthalmic percutaneous absorption type preparation
US8101654B2 (en) Percutaneously absorptive ophthalmic preparation comprising olopatadine
EP1754491B1 (en) Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
KR20080034916A (ko) 에피나스틴을 포함하는 경피 흡수 안과 제제
JPWO2004041270A1 (ja) 3−メチル−1−フェニル−2−ピラゾリン−5−オン含有経皮吸収製剤
US20030125308A1 (en) Antipruritic agents for external use
US20050158371A1 (en) Novel external agent
US20210369636A1 (en) Lidocaine-Containing Patch
US20110124727A1 (en) Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation
KR20070018755A (ko) 무스카린 수용체 작동약을 함유한 안과용 경피흡수형 제제
KR102455157B1 (ko) 로피니롤 경피흡수제
EP1917964A1 (en) Percutaneously absorbable ophthalmic preparation
JPWO1996004902A1 (ja) 外用剤組成物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080205

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20110706

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20121116

Patent event code: PE09021S01D

AMND Amendment
E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20130530

Patent event code: PE09021S02D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20140224

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130530

Comment text: Final Notice of Reason for Refusal

Patent event code: PE06011S02I

Patent event date: 20121116

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20140526

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20140224

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2014101003100

Request date: 20140526

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20140526

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20130927

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20130116

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20110706

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20140725

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20140526

Effective date: 20160728

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20160728

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20140526

Decision date: 20160728

Appeal identifier: 2014101003100